Armis Advisers’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Armis Advisers's AMGN Position: Q2 2026 in Review
Armis Advisers increased its Amgen (AMGN) stake by 5.3% in Q2 2026, buying an estimated $111K and bringing the position to 6,418 shares worth $2.35M. The position accounts for 0.22% of the portfolio, ranked #78.
Armis Advisers first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 586 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Armis Advisers held 6,418 shares of Amgen worth $2.35M as of Q2 2026.
- Armis Advisers bought 323 Amgen shares in Q2 2026, an estimated $111K.
- Amgen made up 0.22% of Armis Advisers's portfolio in Q2 2026, its #78 holding.
- Armis Advisers first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 586 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.